Analysis of Prothrombin Time in Hepatitis C Patients
DOI:
https://doi.org/10.71395/ijhp.2.3.2025.4Abstract
Background and Objectives: Various clotting proteins are synthesized in the liver and any impairment in the liver results in multiple coagulation abnormalities. To determine the prevalence of increased level of Prothrombin Time (PT) in patients with cirrhosis and to compare the levels of Prothrombin Time along with International Nor- malized Ratio (INR) in patients of Hepatitis C with and without Liver Cirrhosis.
METHODOLOGY: A retrospective study was conducted in Sheikh Zaid Hospital, Lahore in the Gastroenterolo-
gy department. The study was conducted during the 3 months from May to July, 2023. The study involved 80 patients, out of which 43 were females and 37 were males with multiple age groups ranging from 30 to 85 years. These patients were further divided into 55 patients with Hepatitis C without liver cirrhosis and 25 patients with Hepatitis C with liver Cirrhosis. Immuno-Assay Special Chemistry Analyzer (Access 2) and Sysmex CS-1600 were used to detect the HCV positive patients and to analyze the coagulation profile. A self-designed Performa was used to collect the patient data. Data were entered and analyzed by using excel and displayed by using Tables and Bar Charts.
RESULTS: The results indicated that out of 80 patients Prothrombin Time (PT) was normal in 26 patients of Hep- atitis C without Cirrhosis, high in 34 patients of Hepatitis C with and without Cirrhosis, and extremely high in 10 patients of Hepatitis C with Cirrhosis. Similarly, International Normalized Ratio (INR) was normal in 14 patients of Hepatitis C without Cirrhosis, high in 59 patients of Hepatitis C with and without Cirrhosis, and abnormally high in 7 patients of Hepatitis C with Cirrhosis.
CONCLUSION: The conclusion of this study is the abnormalities in the coagulation parameter like Prothrombin Time (PT) depend on the severity and intensity of liver disease.
KEYWORDS: Prothrombin Time (PT), International Normalized Ratio (INR), Hepatitis, Cirrhosis, Coagulation Profile.
References
Khan MA. Comparative prevalence of different types of viral hepatitis in the district Dera Ismail Khan, Khyber Pakhtunkhwa, Pakistan. Egyptian Liver Journal. 2022;12(1):40.
Morozov VA, Lagaye S. Hepatitis C virus: Morpho- genesis, infection and therapy. World journal of hepatology. 2018;10(2):186.
Simmonds P. The origin of hepatitis C virus. Hepa- titis C virus: from molecular virology to antiviral therapy. 2013:1-15.
Schmelzer J, Dugan E, Blach S, Coleman S, Cai Z, DePaola M, et al. Global prevalence of hepatitis C virus in children in 2018: a modelling study. The lancet Gastroenterology & hepatology. 2020;5(4):374-92.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Healthcare Professions
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments ijhp@giu.edu.pk
